Drug intelligence / Profile preview

xiaotong

Development stage: Unknown
Lead developer: 奇正藏药
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Xiaotong is a traditional Chinese medicine (TCM) topical herbal drug, primarily formulated as a patch, used for the treatment of musculoskeletal and skin conditions. It is indicated for hyperostosis, periarthritis, and wounds or injuries. The product is developed and manufactured by Tibet Cheezheng Tibetan Medicine Co., Ltd., with regulatory approval in China since 1996. Its mechanism of action is not fully elucidated but it acts through multi-component herbal extracts typical of TCM formulations to provide anti-inflammatory and analgesic effects[1].

Brand names: XiaoTong

Beyond the preview

Go deeper on xiaotong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaotong.

Explore the full profile